U.S. Microbiome Sequencing Services Market Size & Outlook

The microbiome sequencing services market in the United States is expected to reach a projected revenue of US$ 1,326.3 million by 2030. A compound annual growth rate of 10.4% is expected of the United States microbiome sequencing services market from 2024 to 2030.
Revenue, 2023 (US$M)
$662.2
Forecast, 2030 (US$M)
$1,326.3
CAGR, 2024 - 2030
10.4%
Report Coverage
U.S.

U.S. microbiome sequencing services market, 2018-2030 (US$M)

U.S.

Related Markets

U.S. microbiome sequencing services market highlights

  • The U.S. microbiome sequencing services market generated a revenue of USD 662.2 million in 2023 and is expected to reach USD 1,326.3 million by 2030.
  • The U.S. market is expected to grow at a CAGR of 10.4% from 2024 to 2030.
  • In terms of segment, sequencing by synthesis was the largest revenue generating technology in 2023.
  • Sequencing by synthesis is the most lucrative technology segment registering the fastest growth during the forecast period.


Microbiome sequencing services market data book summary

Market revenue in 2023USD 662.2 million
Market revenue in 2030USD 1,326.3 million
Growth rate10.4% (CAGR from 2023 to 2030)
Largest segmentSequencing by synthesis
Fastest growing segmentSequencing by synthesis
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSequencing by synthesis, Sequencing by ligation, Sanger sequencing
Key market players worldwideMicrobiome Insights Inc., BaseClear, Clinical Microbiomics, Mérieux NutriSciences Corporation, Mr Dna, Metabiomics, Rancho BioSciences, Second Genome, Zymo Research, uBiome


Other key industry trends

  • In terms of revenue, U.S. accounted for 43.9% of the global microbiome sequencing services market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. microbiome sequencing services market is projected to lead the regional market in terms of revenue in 2030.
  • Canada is the fastest growing regional market in North America and is projected to reach USD 127.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Microbiome Sequencing Services Market Scope

Microbiome sequencing services market segmentation & scope
Sequencing by synthesis
Sequencing by ligation
Sanger sequencing
Others
Autoimmune Disorder
Cancer
Gastrointestinal Disorders
Others
Pharmaceutical & biotechnology companies
Academic research institutes
Others

Microbiome Sequencing Services Market Companies

Name Profile # Employees HQ Website

U.S. microbiome sequencing services market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microbiome sequencing services market will help companies and investors design strategic landscapes.


Sequencing by synthesis was the largest segment with a revenue share of 57.01% in 2023. Horizon Databook has segmented the U.S. microbiome sequencing services market based on sequencing by synthesis, sequencing by ligation, sanger sequencing covering the revenue growth of each sub-segment from 2018 to 2030.


The U.S. market accounted for the major revenue share of microbiome sequencing services market. The local presence of several pharmaceutical & biotechnological entities & research institutions in the country and increase in the number of R&D programs related to cancer, infectious disorders, & precision medicine are responsible for the large share of the regional market.

These entities in turn are committed to addressing the unmet medical needs of patients in the U.S. as well as around the world through their studies. Furthermore, the U.S. market is majorly influenced by an increase in the prevalence of cancer and autoimmune disorders including GI disorders, which is boosting the demand for diagnostics for early cancer detection.

Over the past few decades, transcriptome profiling has emerged as a promising approach in the field of oncology, providing predictive and prognostic utility for cancer management. With the development of innovative, novel technologies such as NGS, the field of cancer management is witnessing a revolution.

Reasons to subscribe to U.S. microbiome sequencing services market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of U.S. microbiome sequencing services market databook

  • Our clientele includes a mix of microbiome sequencing services market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the U.S. microbiome sequencing services market , including forecasts for subscribers. This country databook contains high-level insights into U.S. microbiome sequencing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

U.S. microbiome sequencing services market size, by technology, 2018-2030 (US$M)

U.S. Microbiome Sequencing Services Market Outlook Share, 2023 & 2030 (US$M)

U.S. microbiome sequencing services market size, by technology, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more